Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
02/2008
02/06/2008CN100366622C 20(S) camptotheca alkaloid derivatives, their preparing methods and uses
02/06/2008CN100366610C Cyanine compound, optical recording material, and optical recording medium
02/06/2008CN100366609C Salted extract separation of indole
02/06/2008CN100366605C Compounds to treat alzheimer's disease
02/05/2008US7326795 efficient resolution, purification and isolation of intermediate compounds, and a one step neutralization/coupling procedure
02/05/2008US7326794 Process for the preparation of high purity perindopril and intermediates useful in the synthesis
02/05/2008US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions
02/05/2008US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance
02/05/2008US7326780 Label (fluorescence-emitting molecule, hapten-containing molecule, protein, or radioactive chemical) attached to N-(2-chloroethyl)-N-methylaminobenzylamino ligand by a spacer forming a neutralized quaternary ammonium group for covalent attachment to DNA, RNA, or siRNA
02/05/2008US7326696 Amino-methyl substituted tetracycline compounds
02/05/2008US7326511 chemically amplified photoresist comprising compounds which cures upon the action of an acid or whose solubility is increased upon the action of an acid and photosensitive acid generators; give high resolution with good resist profile
02/05/2008US7326506 Bridged charge transport materials having a central sulfur atom linkage
02/05/2008US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
02/05/2008CA2315703C Tripeptidyl peptidase inhibitors
02/05/2008CA2264065C Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
01/2008
01/31/2008WO2008014186A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists
01/31/2008WO2008013856A2 Methods and compositions for production, formulation and use of 1 aryl -3-azabicyclo[3.1.0 ] hexanes
01/31/2008WO2008012782A2 Labelled analogues of halobenzamides as radiopharmaceuticals
01/31/2008WO2008012511A1 Compounds having crth2 antagonist activity
01/31/2008WO2008012347A1 Benzo [f] isoindoles as ep4 receptor agonists
01/31/2008WO2008012344A1 Naphthalene derivatives used as ep4 receptor agonists
01/31/2008WO2007092264B1 Kit for automated resolving agent selection and method thereof
01/31/2008US20080027233 Process for the Preparation of Alkyl 5-(Dicarboximido) Levulinate and Alkyl 4-Oxopentenoate
01/31/2008US20080027218 Hydroformylation Process for Pharmaceutical Intermediate
01/31/2008US20080027125 Fluvastatin sodium novel forms and preparation thereof
01/31/2008US20080027124 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i
01/31/2008US20080027123 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating erythema nodosum leprosum in leprosy, rhematoid spondylitis, hepatitis or congestive heart failure
01/31/2008US20080027122 antidiabetic agents; 4-chloro-3-(4-ethylphenylmethyl)-1-( beta -D-glucopyranosyl)indole; hypoglycemic agent, wound healing agent, antilipemic agents, hypotensive agent; chemical synthesis with a chemical intermediates
01/31/2008US20080027121 Novel pyrone-indole derivatives and process for their preparation
01/31/2008US20080027110 Indolyl-3-glyoxylic acid derivatives having antitumor action
01/31/2008US20080027098 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation
01/31/2008US20080027096 Novel Pharmaceutical Compositions
01/31/2008US20080027090 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease
01/31/2008US20080027074 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole; 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole-7-carboxylic acid methyl ester; attention deficit hyperactivity disorder (ADHD); serotonin, norepinephrine and/or dopamine reuptake inhibitors reuptake inhibitors
01/31/2008US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors
01/31/2008US20080027060 Dipeptide nitriles
01/31/2008US20080027055 1-Substituted indoles, and benzimidazoles additionally substituted with an amino ligand, e.g., 1-[(5-chlorothien-2-yl)sulfonyl]-5-[2-(piperidin-1-yl)ethoxy]-1H-indole; treating schizophrenia, depression, attention deficit disorder, Alzheimer's disease and Parkinson's disease
01/31/2008US20080027038 N-Acylated lipophilic amino acid derivatives
01/31/2008US20080026407 Covalent tethering of functional groups to proteins
01/31/2008DE102006033109A1 Substituierte Heteroaryl-Derivate Substituted heteroaryl derivatives
01/31/2008CA2659055A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists
01/31/2008CA2658496A1 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-yl} acetic acid derivatives and esters thereof having crth2 antagonist activity
01/30/2008EP1882685A1 Method for producing asymmetric tetrasubstituted carbon atom-containing compound
01/30/2008EP1881977A1 Histone deacetylase inhibitors
01/30/2008EP1727886B1 Process for obtaining granular compositions
01/30/2008EP1521757B1 tricyclic spiropiperidines or spiropyrrolidines
01/30/2008CN101115802A Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element
01/30/2008CN101115746A Novell processes for the preparation of a benzofuran
01/30/2008CN101115719A Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
01/30/2008CN101115718A N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid TRPV1 receptor ligands
01/30/2008CN101115717A Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
01/30/2008CN101113148A Dioxygen piperazidine compounds and preparation method and usage thereof
01/30/2008CN100364994C Crystal form of Peimeiqusai disodium and its preparation
01/30/2008CN100364993C Peimequizane salt and its preparation
01/30/2008CN100364975C Medication for anti virus of respiratory tract and application
01/30/2008CN100364974C Method for synthesis of (2s,3as,7as)-perhydroindole-2- carboxylic acid and esters thereof, and use in the synthesis of perindopril
01/30/2008CN100364973C Indolone-acetamide derivatives, processes for preparing them and their uses
01/30/2008CN100364972C Method for preparing 5-hydroxyl tryptophan in high purity
01/29/2008US7323608 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
01/29/2008US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of
01/29/2008US7323575 Process for the synthesis of (2S)-indoline-2-carboxylic acid
01/29/2008US7323488 Chromogenic enzyme substrates
01/29/2008US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
01/29/2008US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
01/29/2008US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity
01/29/2008US7323470 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection
01/29/2008US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
01/29/2008US7323286 Exposure latitude and line-edge roughness
01/24/2008WO2008010831A1 An oxidation process for the preparation of n-[3-amino-1- (cyclobutylmethyl)-2,3-dioxopropyl]-3-{n-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0] hexane-2-carboxamide and related compounds
01/24/2008WO2008010481A1 Aminoindan derivative or salt thereof
01/24/2008WO2008010433A1 Bridged cyanine compounds and optical recording materials containing the same
01/24/2008WO2008010377A1 Carbazole-containing amine compound and use thereof
01/24/2008WO2008010238A2 Antidiabetic azabicyclo [3. 1. 0] hexan compounds
01/24/2008WO2008009924A2 Indoles useful in the treatment of inflammation
01/24/2008WO2008009881A1 Chemical compounds
01/24/2008WO2008009127A1 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
01/24/2008WO2007131907A3 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
01/24/2008WO2007127421A3 Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes
01/24/2008WO2007100894A3 Fluvastatin sodium novel forms and preparation therof
01/24/2008US20080021182 Cocatalyst-reacted bridged imine complexes of silicon or germanium, e.g., N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-diaminocyclohexanesilicon(IV) dichloride and N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-diaminocyclohexanegermanium(IV) dichloride; preparing isotactic polyolefins
01/24/2008US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities
01/24/2008US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders
01/24/2008US20080021082 Small molecule inhibition of a PDZ-domain interaction
01/24/2008US20080021066 Iap inhibitors
01/24/2008US20080021042 Composition For Controlling Neuropathic Pain
01/24/2008US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
01/24/2008US20080021005 Pegylated Ion Channel Modulating Compounds
01/24/2008US20080020986 mimetics of the activity of the N-terminal portion of Smac/tertiary binding structure to IAPs, can be combined with chemotherapeutic agents like topoisomerase inhibitors, kinase inhibitors, NSAIDs, taxanes and platinum containing compounds; increased cell permeability, water solubility; antitumor agents
01/24/2008US20080019942 Novel inhibitors of hepatitis c virus replication
01/24/2008US20080017853 Anthracene derivative, and light-emitting element, light-emitting device, electronic device using anthracene derivative
01/24/2008US20080016674 Method And Installation Means For Installing An Electrical Machine
01/24/2008CA2658433A1 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
01/24/2008CA2658376A1 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexane-1-derivatives having effects of the opioid receptor system
01/24/2008CA2628738A1 An oxidation process for the preparation of n-[3-amino-1- (cyclobutylmethyl)-2,3-dioxopropyl]-3-{n-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0] hexane-2-carboxamide and related compounds
01/23/2008EP1880996A1 Spiroindolinepiperidine derivatives
01/23/2008EP1880993A1 Nitrogen-containing heterocyclic compound
01/23/2008EP1880992A1 Stable modifications of tegaserod hydrogen maleate
01/23/2008EP1879895A1 Enzyme inhibitors
01/23/2008EP1879863A1 Amide resorcinol compounds
01/23/2008EP1879850A1 Acrylic ester compound and manufacturing intermediate thereof, method for manufacturing acrylic ester compound, and latent electrostatic image bearing member, image forming method, image forming apparatus and process cartridge